WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:
| B. Riley Securities 25th Annual Investor Conference | |
| Date: | Thursday, May 22, 2025 |
| Format: | 1x1 Meetings & Fireside Chat |
| Location: | The Ritz-Carlton, Marina del Rey |
| Stifel 2025 Boston Cross Sector 1x1 Conference | |
| Date: | Tuesday, June 3, 2025 |
| Format: | 1x1 Meetings |
| Location: | InterContinental Boston |
| 45th Annual William Blair Growth Stock Conference | |
| Date: | Thursday, June 5, 2025 |
| Format: | 1x1 Meetings |
| Location: | Loews Chicago Hotel |
| The Citizens Medical Devices and Healthcare Services Forum | |
| Date: | Tuesday, June 17, 2025 |
| Format: | 1x1 Meetings |
| Location: | Boston Harbor Hotel |
To request a meeting or for more details about the conferences please reach out to your institutional contact.
About OptimizeRx
OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.
OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Relations Contact
Steven Halper
LifeSci Advisors, LLC
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$12.09 |
| Daily Change: | 0.48 4.13 |
| Daily Volume: | 216,806 |
| Market Cap: | US$222.700M |
May 12, 2025 December 23, 2024 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
